Clondalkin Pharma & Healthcare is categorized under Offset Printing in Indianapolis, IN .
Clondalkin Pharma & Healthcare was established in 0, and today employs 1 to 4, earning $100.000.000 to $499.999.999 per year. This is a Offset Printing business, which does work in the B2B market, and is classified as a Offset Printing, under code number 4242101 by the NAICS.
If you are seeking more information, feel free to contact Dan Koch, Manufacturing Executive at the company’s branch by writing to 6454 Saguaro Court, Indianapolis, Indiana IN 46268 or by phoning (317) 328-7355. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Clondalkin Pharma & Healthcare |
| Contact Person: | Dan Koch, Manufacturing Executive |
| Address: | 6454 Saguaro Court, Indianapolis, Indiana 46268 |
| Phone Number: | (317) 328-7355 |
| Website Address: | clondalkingroup.com |
| Annual Revenue (USD): | $100.000.000 to $499.999.999 |
| Location Type: | Branch |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Offset Printing |
| SIC Code: | 2752 |
| NAICS Code: | 4242101 |
| Share This Business: |
Clondalkin Pharma & Healthcare was started in 0 to provide professional Offset Printing under the SIC code 2752 and NAICS code 4242101. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000.000 to $499.999.999 per annum.
Feel free to contact Dan Koch, Manufacturing Executive for inquiries that concern Clondalkin Pharma & Healthcare by calling the company number (317) 328-7355, as your correspondence is most welcome. Additionally, the physical location of the branch of Clondalkin Pharma & Healthcare can be found at the coordinates 39.87292,-86.23612 as well as the street address 6454 Saguaro Court in Indianapolis, Indiana 46268.
For its online presence, you may visit Clondalkin Pharma & Healthcare’s website at clondalkingroup.com and engage with its social media outlets through on Twitter and on Facebook.